TGFB1 and breast carcinoma: They found that miR-128a, previously identified as being associated with breast cancer aggressiveness [27], was highly expressed in letrozole-resistant breast cancer cells compared with their sensitive counterpart and targeted the transforming growth factor β (TGF-β) signaling pathway.